Neuropsychiatric adverse effects on dolutegravir-Reference-Cited by-同舟云学术

Neuropsychiatric adverse effects on dolutegravir

Published:2017-05-15 Issue:8 Volume:31 Page:1201-1203
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Menard Amélie,Montagnac Clementine,Solas Caroline,Meddeb Line,Dhiver Catherine,Tomei Christelle,Ravaux Isabelle,Tissot-Dupont Herve,Mokhtari Saadia,Colson Philippe,Stein Andreas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference5 articles.

1. Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients;Borghetti;AIDS,2017

2. Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir;Bonfanti;AIDS,2017

3. Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients;Hoffmann;HIV Med,2017

4. Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practice;de Boer;AIDS,2016

5. Brief report: dolutegravir plus abacavir/lamivudine for the treatment of HIV-1 infection in antiretroviral therapy-naive patients: week 96 and week 144 results from the SINGLE randomized clinical trial;Walmsley;J Acquir Immune Defic Syndr,2015

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cohort profile: longitudinal and population comparison of children who are HIV-exposed uninfected and children who are HIV unexposed in Kenya (HOPE study);BMJ Open;2024-06

2. Immunovirological response and adverse effects of dolutegravir-based regimen in people living with HIV/AIDS;Journal of Medical Society;2024-01

3. Central nervous system disorders after use of dolutegravir: evidence from preclinical and clinical studies;Pharmacological Reports;2023-08-21

4. Real-Life Experience on Dolutegravir and Lamivudine as Initial or Switch Therapy in a Silver Population Living with HIV;Viruses;2023-08-15

5. Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study;Frontiers in Cellular and Infection Microbiology;2023-06-26